Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Humanized CD7 CAR-T for CD7+ Acute Leukemia
NCT04762485Phase 2Unknown
- Sponsor
- First Affiliated Hospital of Soochow University
- Start
- Jun 2021
- Primary completion
- Feb 2023
- Modality
- Gene Editing, Gene Silencing, CAR-T Cells
- Countries
- 1
01
Overview
A Phase 2 trial of PA3-17 in t-cell acute lymphoblastic leukemia (T-ALL), acute myeloid leukemia (AML), mixed phenotype acute leukemia (MPAL), T cell lymphoblastic lymphoma (T-LBL), sponsored by First Affiliated Hospital of Soochow University. Status: unknown.
02
Drugs
PA3-17
03
Conditions
t-cell acute lymphoblastic leukemia (T-ALL)acute myeloid leukemia (AML)mixed phenotype acute leukemia (MPAL)T cell lymphoblastic lymphoma (T-LBL)
Beyond the preview
Go deeper on NCT04762485.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04762485.